Announced
Completed
Synopsis
Avidity Partners, an investment management firm that offers financial services, led a $50m Series D funding round in Calyxo, a medical device company developing next-generation treatment solutions for patients with kidney stones, with participation from Questa Capital and CRG. “We are excited about this round of funding which will further accelerate the company’s momentum. Despite the challenging market conditions, we received strong support from investors who believe in our team, our mission and the promise of our CVAC technology. Our kidney stone treatment innovations will improve care for patients and have the opportunity to transform the way this condition is treated. We will use this capital to build commercial traction while maintaining investment in product development and clinical studies,” Joe Catanese Calyxo President & CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.